KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) EPS (Basic): 2018-2024

Historic EPS (Basic) for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $0.66.

  • Castle Biosciences' EPS (Basic) fell 125.00% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.41, marking a year-over-year decrease of 286.36%. This contributed to the annual value of $0.66 for FY2024, which is 130.84% up from last year.
  • Latest data reveals that Castle Biosciences reported EPS (Basic) of $0.66 as of FY2024, which was up 130.84% from -$2.14 recorded in FY2023.
  • Castle Biosciences' 5-year EPS (Basic) high stood at $0.66 for FY2024, and its period low was -$2.58 during FY2022.
  • Its 3-year average for EPS (Basic) is -$1.35, with a median of -$2.14 in 2023.
  • In the last 5 years, Castle Biosciences' EPS (Basic) plummeted by 254.29% in 2020 and then skyrocketed by 130.84% in 2024.
  • Over the past 5 years, Castle Biosciences' EPS (Basic) (Yearly) stood at -$0.54 in 2020, then tumbled by 129.63% to -$1.24 in 2021, then tumbled by 108.06% to -$2.58 in 2022, then rose by 17.05% to -$2.14 in 2023, then soared by 130.84% to $0.66 in 2024.